Getting to market faster with molecular diagnostic method development
Developing new, accurate, less intrusive, early-stage, and cost-efficient diagnostic methods is one of the major objectives in the pharma industry.
Finding signatures that could predict or detect a disease in the early stages is an intrinsic multidisciplinary process that can help to accelerate method development when executed correctly.
Our multi-omics capability and experience make us the perfect partner during the pre-clinical research and development stages of diagnostic method development. Whether the goal is to identify a specific molecule (metabolite or nucleic acid) or a signature associated with specific disease, our team can design and execute the right assay for your research.
We make sure your method is the most time-effective, cost-effective, and easy to translate as possible within a regulatory environment.
At Eremid, we understand that you face many challenges in your research. That’s why our Genomics, Metabolomics, NMR, and Bioinformatics services are fully customizable to ensure you can efficiently and rapidly reach your molecular diagnostic method development goals.
Additional areas of human health expertise: